Sentinel Lymph Node Biopsy

• 

  Subject Areas on Research

  • ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy. 
  • ASO Author Reflections: Moving the Ball Forward Toward De-Escalation of Axillary Surgery for Patients with Clinically Node-Positive Disease. 
  • Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy. 
  • Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. 
  • American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. 
  • Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. 
  • Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. 
  • Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? 
  • Axillary lymph node dissection versus the sentinel lymph node technique in breast cancer. 
  • Breast cancer. Clinical practice guidelines in oncology. 
  • Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? 
  • Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. 
  • Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Colon sentinel lymph node mapping: practical surgical applications. 
  • Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. 
  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. 
  • Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance. 
  • Contemporary Approaches to In-Transit Melanoma. 
  • Diagnostic accuracy of whole slide imaging for cutaneous, soft tissue, and melanoma sentinel lymph node biopsies with and without immunohistochemistry. 
  • Discussion. 
  • Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection. 
  • Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma? 
  • Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. 
  • Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma. 
  • Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer. 
  • Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. 
  • Final results of the Department of Defense multicenter breast lymphatic mapping trial. 
  • FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. 
  • Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. 
  • High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? 
  • Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis. 
  • Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. 
  • Impact of delayed lymphoscintigraphy for sentinel lymphnode biopsy for breast cancer. 
  • Importance of sentinel lymph node biopsy in patients with thin melanoma. 
  • Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. 
  • Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment. 
  • Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. 
  • Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. 
  • Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. 
  • Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. 
  • Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? 
  • Is there a role for sentinel lymph node biopsy in the management of sarcoma? 
  • Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. 
  • Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. 
  • Low-Volume Lymph Node Metastases in Endometrial Carcinoma. 
  • Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. 
  • Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. 
  • Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. 
  • Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. 
  • Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. 
  • Lymphatic mapping and sentinel node analysis: current concepts and applications. 
  • Lymphatic mapping and sentinel node identification for colorectal cancer. 
  • Melanoma patients evaluated by four different positron emission tomography reconstruction techniques. 
  • Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. 
  • Minimally invasive operation for breast cancer. 
  • Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. 
  • Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. 
  • Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients? 
  • Paravertebral somatic nerve blocks for breast surgery in a patient with hypertrophic obstructive cardiomyopathy. 
  • Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011. 
  • Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. 
  • Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. 
  • Pediatric melanoma: a single-institution experience of 150 patients. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. 
  • Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. 
  • Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer. 
  • Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. 
  • Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network-Can We Translate Results From Randomized Trials Into the Clinic? 
  • Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. 
  • Recurrence after mastectomy for ductal carcinoma in situ. 
  • Regional Nodal Irradiation in the Modern Era of Breast Cancer Management. 
  • Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. 
  • SPECT/CT: Looking Beyond Sentinel Lymph Node Identification for Improving Patient Outcomes. 
  • Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. 
  • Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. 
  • Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study. 
  • Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. 
  • Sentinel lymph node biopsy following a rotational flap. 
  • Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 
  • Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma. 
  • Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. 
  • Sentinel lymph node detection using laser-assisted indocyanine green dye lymphangiography in patients with melanoma. 
  • Sentinel node biopsy for head and neck melanoma: a systematic review. 
  • Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. 
  • Sentinel node staging of resectable colon cancer: results of a multicenter study. 
  • Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. 
  • Surgery for Men with Breast Cancer: Do the Same Data Still Apply? 
  • Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. 
  • Surgical management of cutaneous melanoma: current practice and impact on prognosis. 
  • Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. 
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. 
  • The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer. 
  • The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations. 
  • The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. 
  • The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. 
  • The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. 
  • The impact of nodal isolated tumor cells on survival of breast cancer patients. 
  • The impact of shave biopsy on the management of patients with thin melanomas. 
  • The sentinel node in colorectal carcinoma. Mapping technique, pathologic assessment, and clinical relevance. 
  • The triangular intermuscular space as a site of lymph node metastasis in melanoma of the back. 
  • Transected thin melanoma: Implications for sentinel lymph node staging. 
  • Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. 
  • Two-day lymphoscintigraphic imaging for melanoma. 
  • Updates on Merkel Cell Carcinoma. 
  • Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer. 
  • Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. 
  • What's new in general surgery: surgical oncology. 
  • What's new in neoadjuvant therapy for breast cancer? 
  • [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial. 
• 

  Keywords of People

  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology